BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20670480)

  • 1. Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis.
    Li Y; Zhu X; Gu J; Hu H; Dong D; Yao J; Lin C; Fei J
    Hematology; 2010 Aug; 15(4):215-21. PubMed ID: 20670480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines.
    Gu J; Zhu X; Li Y; Dong D; Yao J; Lin C; Huang K; Hu H; Fei J
    Med Oncol; 2011 Mar; 28(1):211-8. PubMed ID: 20143188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-181a sensitizes resistant leukaemia HL-60/Ara-C cells to Ara-C by inducing apoptosis.
    Bai H; Cao Z; Deng C; Zhou L; Wang C
    J Cancer Res Clin Oncol; 2012 Apr; 138(4):595-602. PubMed ID: 22209977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-miR-21 oligonucleotide sensitizes leukemic K562 cells to arsenic trioxide by inducing apoptosis.
    Li Y; Zhu X; Gu J; Dong D; Yao J; Lin C; Huang K; Fei J
    Cancer Sci; 2010 Apr; 101(4):948-54. PubMed ID: 20148895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine sensitizes ovarian cancer cells to cisplatin through miR-21/PDCD4 axis.
    Liu S; Fang Y; Shen H; Xu W; Li H
    Acta Biochim Biophys Sin (Shanghai); 2013 Sep; 45(9):756-62. PubMed ID: 23824073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A novel bcl-2 antisense oligodeoxynucleotide F951 increases sensitivity of HL-60 cells to Ara-C].
    Li DL; Lu LH; Chen YY; Lin ZX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):752-6. PubMed ID: 15631654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of miR-141 reverses cisplatin resistance in non-small cell lung cancer cells via upregulation of programmed cell death protein 4.
    Fu WF; Chen WB; Dai L; Yang GP; Jiang ZY; Pan L; Zhao J; Chen G
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(12):2565-72. PubMed ID: 27383306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of miR-17 and miR-20a by oridonin triggers apoptosis and reverses chemoresistance by derepressing BIM-S.
    Weng H; Huang H; Dong B; Zhao P; Zhou H; Qu L
    Cancer Res; 2014 Aug; 74(16):4409-19. PubMed ID: 24872388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.
    Zhang X; Huang L; Zhao Y; Tan W
    Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-16 Promotes Ovarian Granulosa Cell Proliferation and Suppresses Apoptosis Through Targeting PDCD4 in Polycystic Ovarian Syndrome.
    Fu X; He Y; Wang X; Peng D; Chen X; Li X; Wan Q
    Cell Physiol Biochem; 2018; 48(2):670-682. PubMed ID: 30025387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Xu K; Yagüe E
    Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the sensitivity of leukemic cells to arsenic trioxide enhanced by targeted suppression of mIRNA-21].
    Li YM; Gu JY; Zhu XJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Feb; 30(2):170-3. PubMed ID: 20462046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combination regimen of idarubicin and taxotere is effective against human drug-resistant leukemic cell lines.
    Majlessipour F; Avramis IA; Kwock R; Weinberg KI; Avrami VI
    Anticancer Res; 2002; 22(3):1361-8. PubMed ID: 12168812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-21 increases the programmed cell death 4 gene-regulated cell proliferation in head and neck squamous carcinoma cell lines.
    Sun Z; Li S; Kaufmann AM; Albers AE
    Oncol Rep; 2014 Nov; 32(5):2283-9. PubMed ID: 25175929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B1, a novel amonafide analogue, overcomes the resistance conferred by Bcl-2 in human promyelocytic leukemia HL60 cells.
    Liang X; Xu Y; Xu K; Liu J; Qian X
    Mol Cancer Res; 2010 Dec; 8(12):1619-32. PubMed ID: 21076048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptosis in HL60 leukemic cells by anticancer drugs in combination with anti-Fas monoclonal antibody.
    Nakamura S; Takeshima M; Nakamura Y; Ohtake S; Matsuda T
    Anticancer Res; 1997; 17(1A):173-9. PubMed ID: 9066648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense oligonucleotide against miR-21 inhibits migration and induces apoptosis in leukemic K562 cells.
    Hu H; Li Y; Gu J; Zhu X; Dong D; Yao J; Lin C; Fei J
    Leuk Lymphoma; 2010 Apr; 51(4):694-701. PubMed ID: 20141427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MALAT1 knockdown inhibits proliferation and enhances cytarabine chemosensitivity by upregulating miR-96 in acute myeloid leukemia cells.
    Hu N; Chen L; Wang C; Zhao H
    Biomed Pharmacother; 2019 Apr; 112():108720. PubMed ID: 30970520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bcl-2 antisense oligodeoxynucleotide enhances araninosyl cytosine-induced apoptosis of primary leukemia cells].
    Lei XY; Zhang H; He DM
    Ai Zheng; 2002 Dec; 21(12):1301-4. PubMed ID: 12520735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRAIL-induced apoptosis of HL60 leukemia cells: two distinct phenotypes of acquired TRAIL resistance that are accompanied with resistance to TNFalpha but not to idarubicin and cytarabine.
    Klener P; Leahomschi S; Molinsky J; Simonova T; Necas E; Gasova Z; Cermak J; Dolezalova L; Andera L; Zivny J
    Blood Cells Mol Dis; 2009; 42(1):77-84. PubMed ID: 19038561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.